Zynerba Synthetic CBD Gel Fragile X Syndrome Phase 2 Trial Succeeds
Zynerba Pharmaceuticals Announces Positive Top Line Results in ZYN002 Open Label Phase 2 FAB-C Study in Children with Fragile X Syndrome ZYN002 successfully met the primary endpoint and showed...